These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37869015)

  • 1. Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes.
    Ahmad MS; Braoudaki M; Patel H; Ahmad I; Shagufta ; Siddiqui SS
    Front Immunol; 2023; 14():1254911. PubMed ID: 37869015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
    Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
    Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    Sastre D; Baiochi J; de Souza Lima IM; Canto de Souza F; Corveloni AC; Thomé CH; Faça VM; Schiavinato JLDS; Covas DT; Panepucci RA
    BMC Cancer; 2019 Dec; 19(1):1239. PubMed ID: 31864341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling.
    Sun N; Zhang L; Zhang C; Yuan Y
    Cell Mol Biol Lett; 2020; 25():19. PubMed ID: 32206063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Siglec-15 expression in colorectal cancer: association with advanced disease stage and fewer tumor-infiltrating lymphocytes.
    Lu Z; Cheng P; Huang F; Li J; Wang B; Zou S; Zheng Z; Peng C
    J Pathol Clin Res; 2023 Mar; 9(2):121-128. PubMed ID: 36424637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
    Chen YL; Wang GX; Lin BA; Huang JS
    Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.
    Zhang Z; Zhu X
    Yonsei Med J; 2022 Jun; 63(6):520-529. PubMed ID: 35619575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.
    Zhang G; Liu Z; Zhong J; Lin L
    Eur J Clin Invest; 2021 Dec; 51(12):e13607. PubMed ID: 34085707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA
    Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP
    Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-301b-3p facilitates cell proliferation and migration in colorectal cancer by targeting HOXB1.
    Xiong J; Zhang L; Tang R; Zhu Z
    Bioengineered; 2021 Dec; 12(1):5839-5849. PubMed ID: 34488545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer.
    Li WC; Wu YQ; Gao B; Wang CY; Zhang JJ
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31729531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.
    Chen Q; Chen B; Wang C; Hu L; Wu Q; Zhu Y; Zhang Q
    Front Immunol; 2023; 14():1159085. PubMed ID: 37234161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a/miR-143/miR-217/miR-512-mediated regulation of PI3K/AKT and Wnt/β-catenin signaling pathways.
    Ghaemi Z; Mowla SJ; Soltani BM
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194921. PubMed ID: 36804476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1.
    Zhang XL; Xu LL; Wang F
    Cell Biol Int; 2017 Sep; 41(9):1056-1064. PubMed ID: 28707774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.